Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.
Expedition Therapeutics has raised $165.0M in total funding. The most recent round was Series A. The last funding was announced in October 2025.
Expedition Therapeutics's investors include Venrock, Forbion Capital Partners, Novo Holdings, Sofinnova Investments, Sanofi Ventures.
Expedition Therapeutics is headquartered in San Francisco, United States.
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.
Expedition Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Expedition Therapeutics — Funding & Investors." VCBacked, October 9, 2025, https://www.vcbacked.co/company/expedition-therapeutics. Accessed July 25, 2026.
VCBacked. (2025). Expedition Therapeutics — Funding & Investors. Retrieved July 25, 2026, from https://www.vcbacked.co/company/expedition-therapeutics
{{cite web |title=Expedition Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/expedition-therapeutics |website=VCBacked |access-date=July 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated